Product image of Metoclopramide Hydrochloride Noridem Enterprises (Metoclopramide Hydrochloride Anhydrous) supplied by GNH India

Metoclopramide Hydrochloride Noridem Enterprises

Active Ingredient:
Metoclopramide Hydrochloride Anhydrous
Origin:
EU

Metoclopramide Hydrochloride Noridem Enterprises (Metoclopramide Hydrochloride Anhydrous)

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Hydrochloride Noridem Enterprises, is a dopamine D2 receptor antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It treats nausea, vomiting, gastroparesis, postoperative nausea and vomiting, and migraine‑associated nausea in adult patients.

GNH India supplies Metoclopramide Hydrochloride Noridem Enterprises as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metoclopramide Hydrochloride is used to manage conditions involving nausea, vomiting and delayed gastric emptying.

  • Nausea and vomiting: Reduces frequency and severity of acute and chemotherapy‑induced nausea.
  • Gastroparesis: Improves gastric motility and alleviates symptoms of delayed gastric emptying.
  • Postoperative nausea and vomiting: Prevents and treats nausea after surgical procedures.
  • Migraine‑associated nausea: Relieves nausea accompanying migraine attacks.

How It Works

  • Metoclopramide Hydrochloride blocks dopamine D2 receptors in the chemoreceptor trigger zone, diminishing the vomiting reflex. It also antagonizes peripheral D2 receptors in the gastrointestinal tract, which increases acetylcholine release and enhances smooth‑muscle contractility, thereby accelerating gastric emptying and intestinal transit. The combined central and peripheral actions produce both antiemetic and gastroprokinetic effects, making the drug useful in a variety of gastrointestinal and neurologic conditions.

Side Effects

Metoclopramide Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Drowsiness: feeling of sleepiness or reduced alertness.
  • Fatigue: general tiredness.
  • Restlessness: inner sense of agitation.
  • Diarrhea: loose, watery stools.

Serious or Rare Side Effects

  • Extrapyramidal reactions: acute dystonia, akathisia, or parkinsonism.
  • Tardive dyskinesia: irreversible involuntary movements with long‑term use.

Precautions & Warnings

When prescribing Metoclopramide Hydrochloride, clinicians should consider several safety precautions to minimize risks.

  • Assess renal function: dose adjustment may be needed in impaired clearance.
  • Monitor for extrapyramidal symptoms: watch for dystonia, akathisia, or parkinsonism.
  • Use caution in patients with depression: drug may exacerbate depressive symptoms.
  • Avoid in individuals with known hypersensitivity to metoclopramide or its excipients.
  • Limit use during pregnancy: only if benefits outweigh potential risks.
  • Store at controlled room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Metoclopramide Hydrochloride can interact with other medicines, requiring attention to avoid adverse effects.

Major Interactions (Avoid)

  • MAO inhibitors: risk of hypertensive crisis and serotonin syndrome.
  • CNS depressants (e.g., opioids, benzodiazepines): additive sedation and respiratory depression.
  • Anticholinergic agents: may increase anticholinergic side effects such as dry mouth and constipation.

Moderate Interactions (Monitor Closely)

  • CYP2D6 substrates (e.g., codeine, tramadol): metoclopramide may inhibit metabolism, raising plasma levels.
  • Warfarin: potential alteration of anticoagulant effect, monitor INR.
  • Insulin or oral hypoglycemics: enhanced glucose‑lowering effect, monitor blood sugar.

Frequently Asked Questions

Metoclopramide Hydrochloride is prescribed to treat nausea and vomiting of various origins, to manage postoperative nausea and vomiting, to improve gastric emptying in gastroparesis, and to alleviate nausea associated with migraine attacks.

The drug blocks dopamine D2 receptors in the brain’s chemoreceptor trigger zone, reducing the vomiting reflex, and also antagonizes peripheral D2 receptors, increasing acetylcholine release which enhances gastrointestinal smooth‑muscle activity and speeds gastric emptying.

Dosing is individualized by the prescribing clinician based on the specific indication, patient characteristics, and route of administration. The prescriber determines the appropriate amount, frequency, and duration of therapy.

Safety data are limited; the product is classified as pregnancy category unknown. It should only be used when the potential benefit justifies any possible risk to the fetus, and caution is advised for nursing mothers.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Metoclopramide combines antiemetic and gastroprokinetic actions, whereas many alternatives such as ondansetron act solely on serotonin receptors. This dual mechanism makes it useful for both nausea control and enhancing gastric motility, but it also carries a distinct side‑effect profile.

Store the injectable product at controlled room temperature, typically below 25 °C. Keep it in the original packaging, protect it from light and moisture, and discard any solution that appears discolored or particulate.

The medication is supplied as a sterile injectable solution and may be given by intramuscular or intravenous injection. Administration technique and infusion rate are determined by the healthcare professional according to the clinical situation.

Serious adverse events include extrapyramidal reactions such as acute dystonia or parkinsonism, and the potential for tardive dyskinesia with prolonged use. Prompt recognition and discontinuation are essential if these symptoms develop.

Patients with known hypersensitivity to metoclopramide, those taking MAO inhibitors, or individuals with a history of severe extrapyramidal disorders should avoid the drug. Caution is also advised in patients with uncontrolled hypertension or epilepsy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.